IMTX Stock Analysis: Buy, Sell, or Hold?
IMTX - Immatics N.V. Ordinary Shares
$7.38
-0.16 (-2.12%)
âŧ
5d:
+9.66%
30d:
-11.4%
90d:
-14.48%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 16, 2026
23d
Get Alerted When IMTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: IMTX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: IMTX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: IMTX is currently trading at $7.38, which is considered fair relative to its 30-day fair value range of $7.26 to $8.65.
Technical Outlook: Technically, IMTX is in a strong downtrend. Immediate support is located at $6.65, while resistance sits at $7.95.
Market Sentiment: IMTX scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $17.26 (+128.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMTX is in a strong downtrend. Immediate support is located at $6.65, while resistance sits at $7.95.
Market Sentiment: IMTX scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $17.26 (+128.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$7.26 -
$8.65
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 128.9% below Wall St target ($17.26)
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.26 -
$8.65
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$6.65
Resistance Level
$7.95
Current Trend
Strong Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.72
Wall Street Target
$17.26
(+128.9%)
Revenue Growth (YoY)
93.0%
Share & Embed Analysis
Last updated: October 23, 2026 10:55 AM ET
Data refreshes hourly during market hours. Next update: 11:55 AM
Data refreshes hourly during market hours. Next update: 11:55 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 62 BUY |
|
REGN
Regeneron PharmaceuticalâĻ |
BUY
28 analysts |
$864 | 44 HOLD |
|
PRAX
Praxis Precision MedicinâĻ |
STRONG BUY
20 analysts |
$650 | 61 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 57 HOLD |
|
ACAD
ACADIA Pharmaceuticals IâĻ |
STRONG BUY
20 analysts |
$31 | 66 BUY |
